Targeted Therapy Enhertu’s Cross Tumor Approval Physician-Scientist Gerold Meinhardt From Drugmaker Daiichi Sankyo On The Huge Implications & The Next Round of HER2 Research

Enhertu, a newly FDA-approved therapy, is one of the few drugs that can effectively treat multiple cancer types by targeting HER2 expression.